News Column

Xiangxue Pharmaceutical 2013 Net Expected to Up 35%-60%

January 20, 2014

GUANGZHOU , January 20 , SinoCast -- Xiangxue Pharmaceutical Co., Ltd. (SZSE: 300147) predicted net profit attributable to shareholders between CNY 145 million and CNY 170 million in 2013, rising 35% to 60% from a year earlier, when the figure was CNY 107 million . 2013 profit growth resulted from adjustment of product portfolio, steady increase of sales revenue from major products. Traditional Chinese medicine decoction pieces became new growth pole.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Sinocast Health Care & Medicine Beat (China)

Story Tools